ERBB2 and breast carcinoma: In contradistinction to many of the published studies investigating imaging biomarkers of HER2 status, which have correlated brain MRI imaging parameters with the HER2 status of the primary breast cancer [26–29], our study correlated 18F-FDG PET uptake with the HER2 status of the breast cancer brain metastases.